IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4802
Positioning
Market Dominance
Retail Trade
Restaurants, Hotels, Motels
$984M
Elias Sacal Cababie
Detailed business profile pending verification.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = MRNO ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ARCO Arcos Dorados Holdings Inc. | 73 | 85 | 89 | 65 | - | - | 29.1% | 5.1% | 46.8% | 7.3% | 3.3% | 3.2% | 3.4% | 153.0x | $1.5B | VS | |
$IMKTA INGLES MARKETS INC | 70 | 73 | 89 | 76 | 11.3x | 4.1x | 5.3% | 3.3% | 23.9% | 2.2% | 1.6% | -5.4% | 1.0% | 32.0x | $1.3B | VS | |
$SGU STAR GROUP, L.P. | 69 | 82 | 79 | 63 | - | - | 26.2% | 7.8% | 31.5% | 6.4% | 4.1% | 1.0% | 6.1% | 63.0x | $399M | VS | |
$EZPW EZCORP INC | 68 | 77 | 82 | 89 | 7.2x | 4.2x | 12.0% | 6.4% | 58.6% | 11.7% | 8.6% | 9.7% | 0.0% | 51.0x | $1.2B | VS | |
$HTHT H World Group Ltd | 68 | 91 | 44 | 84 | - | - | 24.9% | 4.9% | 100.0% | 21.8% | 13.0% | 6.2% | 2.9% | 45.0x | $101.1B | VS | |
$DDL Dingdong (Cayman) Ltd | 68 | 86 | 82 | 57 | - | - | 42.4% | 4.0% | 100.0% | 0.9% | 1.3% | 12.3% | 0.0% | 201.0x | $1.2B | VS | |
$SBH Sally Beauty Holdings, Inc. | 68 | 83 | 92 | 77 | 5.1x | 2.3x | 27.5% | 6.9% | 51.6% | 8.9% | 5.3% | -0.4% | 0.0% | 177.0x | $1.6B | VS | |
$SPH SUBURBAN PROPANE PARTNERS LP | 67 | 80 | 90 | 53 | - | 13.0x | 18.6% | 4.7% | 60.7% | 14.4% | 7.4% | 7.9% | 7.1% | 202.0x | $1.2B | VS | |
$IHG INTERCONTINENTAL HOTELS GROUP PLC /NEW/ | 67 | 63 | 81 | 67 | - | - | -29.5% | 13.1% | 58.6% | 40.7% | 27.4% | 6.8% | 1.3% | - | $21.5B | VS | |
$ROST ROSS STORES, INC. | 67 | 63 | 55 | 83 | 25.2x | 16.5x | 34.8% | 13.3% | 28.0% | 11.6% | 9.1% | 10.4% | 1.0% | 26.0x | $51.6B | VS | |
$MRNO Murano Global Investments Plc | 24 | 19 | 28 | 0 | - | - | -274.1% | -65.3% | 100.0% | -224.6% | -510.4% | 97.6% | 0.0% | 219.0x | $984M | ||
| SECTOR BENCH | - | - | - | - | - | 21.4x | 9.1x | 8.9% | 2.9% | 36.2% | 3.9% | 1.6% | 3.8% | 0.0% | 0.6x | - | REF |
Murano Global Investments Plc (MRNO) receives a "Avoid" rating with a composite score of 24.1/100. It ranks #4802 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Elias Sacal Cababie
Chief Executive Officer
19
55
26
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for MRNO
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Retail Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for MRNO.
View All RatingsInsufficient data for Financial Analysis
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 19 | 3 | +16ALPHA |
| MOMENTUM | 0 | 0 | 0NEUTRAL |
| VALUATION | 28 | 20 | +8ALPHA |
| INVESTMENT | 55 | 94 | -39DRAG |
| STABILITY | 26 | 16 | +10ALPHA |
| SHORT INT | 54 | 64 | -10DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -11.9% vs WACC 5.9% (spread -17.8%)
GM 100% vs sector 36%, OM -225% vs sector 4%
Capital turnover 0.07x
Rev growth 98%, 2yr history
Interest coverage -2.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Murano Global Investments Plc with an Avoid rating, assigning a composite score of 24.1/100 and 1 out of 5 stars. Ranked #4802 of 7,333 stocks, MRNO falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Murano Global Investments Plc registers a weak quality score of just 19/100, indicating significant profitability challenges. The company reports a return on equity of -274.1% (sector avg: 8.9%), gross margins of 100.0% (sector avg: 36.2%), net margins of -510.4% (sector avg: 1.6%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
MRNO registers a value score of just 28/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.21x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 55/100, MRNO exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 97.6% vs. a sector average of 3.8% and a return on assets of -65.3% (sector: 2.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
Murano Global Investments Plc is experiencing notably weak momentum with a score of just 0/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 97.6% year-over-year, while a beta of 0.41 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
MRNO's stability score of 26/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.41 and a debt-to-equity ratio of 219.00x (sector avg: 0.6x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 54/100 for MRNO suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 219.00x), small-cap liquidity risk. With a $984M market cap (small-cap), Murano Global Investments Plc may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Murano Global Investments Plc is a small-cap company in the Retail Trade sector, ranked #0 of 50 in its sector (100th percentile) and #4802 of 7,333 overall (35th percentile). Key comparisons include ROE of -274.1% trailing the 8.9% sector median and operating margins of -224.6% below the 3.9% sector average. This top-quartile standing reflects exceptional competitive strength relative to Retail Trade peers.
While MRNO currently exhibits a AVOID profile, superior opportunities exist within the RETAIL TRADE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Retail Trade Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (0) would have the largest impact on the composite score.
ROE 3178% BELOW SECTOR MEDIAN
Gross Margin 176% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 5836% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate Murano Global Investments Plc (MRNO) as Avoid with a composite score of 24.1/100 at a current price of $0.64. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in investment (55th percentile) and value (28th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (0th percentile) and quality (19th percentile) tempers our overall conviction. We assign a No Moat rating (28/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; balance sheet deleveraging progress; sustainability of the current growth rate. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Murano Global Investments Plc holds a top-quartile position (#0 of 50) within the Retail Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 24.1/100 places it at rank #4802 in our full 7,333-stock universe. At $984M in market capitalization, Murano Global Investments Plc is a small-cap player in the Retail Trade space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 98%, though momentum at the 0th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 100% (+63.8pp vs sector) narrow to operating margins of -225% (-228.5pp vs sector) and net margins of -510.4%, yielding a gross-to-net conversion rate of -510%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.64, Murano Global Investments Plc is trading at a premium to fundamental value. Our value factor score of 28/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 0.2x, P/S of 0.4x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 100% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 98% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
The Avoid rating (composite 24.1/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (219% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -510.4% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Very High uncertainty rating to Murano Global Investments Plc. The stock exhibits multiple compounding risk factors: significant leverage (219% debt-to-equity), current negative profitability (net margin -510.4%), below-average price stability (26th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: significant leverage (219% debt-to-equity); current negative profitability (net margin -510.4%); below-average price stability (26th percentile); weak quality scores (19th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 26th percentile and quality factor at the 19th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 100% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Murano Global Investments Plc's capital allocation as Poor. Key concerns include low returns on equity (-274.1%), elevated leverage (219% D/E), negative profitability, weak asset returns (ROA -65.3%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Murano Global Investments Plc significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Murano Global Investments Plc receives a Avoid rating with a composite score of 24.1/100 (rank #4802 of 7,333). Our quantitative framework assigns a No Moat (28/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 26/100.
Our analysis does not support a constructive view on Murano Global Investments Plc at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Murano Global Investments Plc a meaningful economic moat, scoring 28/100 on our composite assessment. The ROIC-WACC spread of -17.8% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, growth durability, reached only 13/20.
The strongest moat sources are growth durability (13/20) and margin superiority (10/20). Rev growth 98%, 2yr history. GM 100% vs sector 36%, OM -225% vs sector 4%. These pillars form the core of Murano Global Investments Plc's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and financial resilience (1.7/20). Capital turnover 0.07x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Murano Global Investments Plc's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 100% providing a solid profitability foundation, robust top-line growth of 98% expanding the revenue base. The margin cascade from 100% gross to -225% operating to -510.4% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 19th percentile.
The margin profile shows gross margins of 100%, operating margins of -225%, net margins of -510.4%. Return metrics include ROE of -274.1% and ROA of -65.3%. Relative to the Retail Trade sector, gross margins are 63.8 percentage points above the sector median of 36%, and ROE of -274.1% compares to a sector median of 8.9%.
The balance sheet reflects high leverage with D/E of 219%, which may limit financial flexibility, revenue growth of 98%. The sector median D/E is 1%, putting Murano Global Investments Plc at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Weak momentum (0th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
Below-average quality (19th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
Above 50MA
37.18%
Net New Highs
+51081

Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 152% to $0.7242 after the company announced upgrades to its integration with Microsoft Advertising. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 75% to $1.9698 after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04. Infobird Co., Ltd (NASDAQ: IFBD) surged 45.3% to $6.00. ReTo Eco-Solutions, Inc. (NASDAQ: RETO) gained 45% to $1.67. Meiwu Technology Company Limited (NASDAQ: WNW) shares jumped 36% to $1.37. Nano Labs Ltd (NASDAQ: NA) surged 31.6% to $1.9502. Nano Labs recently filed annual report on Form 20-F for fiscal year 2023. iCoreConnect Inc. (NASDAQ: ICCT) shares jumped 30.8% to $1.4650. iCoreConnect, last month, closed $2,375,000 convertible note financing. Dogness (International) Corporation (NASDAQ: DOGZ) climbed 22.9% to $8.48. NeoVolta Inc. (NASDAQ: NEOV) surged 18% to $2.0826. BioSig Technologies, Inc. (NASDAQ: BSGM) rose 18% to $1.92. Verb Technology Company, Inc. (NASDAQ: VERB) climbed 18% to $0.2099. Jaguar Health, Inc. (NASDAQ: JAGX) gained 16.7% to $0.1050 after the company reported approval for all proposals at its special meeting of stockholders. Murano Global Investments Plc (NASDAQ: MRNO) rose 13.6% to $11.70. Gaucho Group Holdings, Inc. (NASDAQ: VINO) surged ...

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ: AUUD) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. Longeveron Inc. (NASDAQ: LGVN) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering. UTime Limited (NASDAQ: WTO) gained 56.8% to $0.29 after the company completed a private placement. U Power Limited (NASDAQ: UCAR) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China. Arrowroot Acquisition Corp. (NASDAQ: ARRW) rose 38.2% to $19.53. Destiny Tech100 Inc. (NASDAQ: DXYZ) jumped 33.8% to $79.30 after jumping around 77% on Friday. TechPrecision Corporation (NASDAQ: TPCS) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies. Adlai Nortye Ltd. (NASDAQ: ANL) gained 27.9% to $10.68. Connexa Sports Technologies Inc. (NASDAQ: CNXA) surged 26.8% to $0.3801. AXT, Inc. (NASDAQ: AXTI) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) climbed 24.4% to $8.70. Apartment Income REIT Corp. (NYSE: AIRC) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion. GD Culture Group Limited (NASDAQ: GDC) rose 22% to $1.1195. Outset Medical, Inc. ...

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ: NXTT) rose 57.4% to $6.42. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder. VivoPower International PLC (NASDAQ: VVPR) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million. Next.e.GO N.V. (NASDAQ: EGOX) gained 32.7% to $0.0345. XTI Aerospace, Inc. (NASDAQ: XTIA) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc. Brooge Energy Limited (NASDAQ: BROG) gained 28.8% to $3.0790. Addex Therapeutics Ltd (NASDAQ: ADXN) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix. Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) gained 24.3% to $0.3981 after gaining 13% on Tuesday. LAMF Global Ventures Corp. I (NASDAQ: LGVC) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Quhuo Limited (NASDAQ: QH) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023. Destiny Tech100 Inc. (NYSE: DXYZ) gained 21.4% to $25.77. OneMedNet Corporation (NASDAQ: ONMD) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement ...

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...